ClinicalTrials.gg
CompletedNCT04504266POWERUpdated Nov 16, 2026

Perioperative Optimization With Enhanced Recovery

An interventional study of POWER in Complication of Surgical Procedure, sponsored by Stanford University. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-16.

Sponsored by Stanford University · Not applicable, Interventional, and Prevention

How we know

Updated Nov 16, 2026Now CompletedPrimary completion moved+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
368
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 35 studies in Motor Activity by Stanford University — 7 open to participants now, 8 under way, none of them phase 3. Motor Activity · Stanford University.

Enrollment
5th of 33
368 · median 79
Started
2020
with 1 other
No phase
28 of 35
7 open now
Registered
24th of 35
by date

Among the 35 studies in Motor Activity by Stanford University, this one is the 5th largest by enrollment of the 33 interventional ones that give a count, is one of 2 that started in 2020, is one of 28 with no phase, and was the 24th registered.

Motor Activity

9,827 studies on the registry are indexed under Motor Activity; 1,911 are open to participants now.

Browse Motor Activity studies →

Open to participants now

7 of the 35 studies in Motor Activity by Stanford University are open now, in 1 country. Recruiting first, the newest first:

2 more — sign in →

By country, each count listing its studies:

All 7 open studies →

Where they have run

Who these studies take

Of the 1,207 Motor Activity studies recruiting now, 524 (43%) set no upper age limit and 538 (45%) stop at 75 or younger; 180 take children under 18; 420 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 35 studies in Motor Activity by Stanford University, or all of them as a file.
02

Study summary

This is a randomized controlled trial examining the effect of a motivational interview and perioperative mobile-app based nutrition and exercise intervention on surgical outcomes. The hypothesis is that such an intervention will improve surgical outcomes. Patients who are planned to undergo major elective abdominal surgery will be randomized to standard care or the nutrition/exercise intervention. This intervention consists of a mobile-app based coaching program to encourage patients to exercise and adopt a Mediterranean diet in the 3+ weeks prior to surgery.

03

Conditions studied

  • Complication of Surgical Procedure

Browse trials for

Keywords

  • prehabilitation, exercise, nutrition
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • major abdominal surgery in 3+ weeks
  • English or Spanish speaking

Exclusion criteria

Exclusion Criteria:

  • Unable to use smartphone
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
368 participants (actual)

Study arms

  • No intervention
    Control Arm

    Recommendations to follow Mediterranean diet and exercise regularly before surgery.

  • Experimental
    Prehab

    This intervention consists of a motivational interview and a mobile-app based coaching program to encourage patients to exercise and adopt a Mediterranean diet in the 3+ weeks prior to surgery.

    Behavioral: POWER

Interventions

  • BehavioralPOWER

    This intervention consists of a motivational interview and a mobile-app based coaching program to encourage patients to exercise and adopt a Mediterranean diet in the 3+ weeks prior to surgery.

06

What researchers measure

Primary outcomes

  1. Surgical Complications occurring in the 90 day post-operative period, measured by the comprehensive complication index

    The comprehensive complication index is an integrated score from 0 to 100 of all complications occurring in a specified time period and their severities as categorized by Clavien-Dindo classification. Calculation of the CCI is via a web-based calculator (www.assessurgery.com).

    Time frame: 90 days after surgery

Secondary outcomes

  1. Change in 6 minute walk test

    Participants will be asked to walk as fast they can for 6 minutes using a validated mobile application (Timed Walk) to measure the distance walked.

    Time frame: It will take about 6 minutes to assess, and this will be performed at enrollment, right before surgery, and at 30 and 90 days after surgery

07

Study locations

1 site
08

References and documents

Publications

  • Kimura C, Liu Y, Crowder SE, Arbaugh C, Mai U, Shankar K, Shelton A, Visser B, Kin C. Barriers and Facilitators of Surgical Prehabilitation Adherence from the Patient Perspective: a Mixed Method Study. J Gastrointest Surg. 2023 Nov;27(11):2547-2556. doi: 10.1007/s11605-023-05857-9. Epub 2023 Oct 17. PubMed 37848690 ↗

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Aug 2020 to primary completion in Sep 2023, 37 months.

Of 5,176 non-industry interventional studies with no phase under Motor Activity, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 36. This study's 37 months is above that.

Counting every sponsor, half of 5,236 studies reached it within 17 months; a quarter within 7 and three quarters within 36.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 16, 2026: primary completion Dec 2024 → Sep 2023 and completion Dec 2024 → Dec 2023.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Aug 5, 2020
First posted
Aug 7, 2020
StartActual
Aug 14, 2020
Primary completionActual
Sep 21, 2023was Dec 2024
CompletionActual
Dec 22, 2023was Dec 2024
Last update
Nov 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Active, not recruiting→Completed
changed Nov 16, 2026
Primary completion
Dec 31, 2024→Sep 21, 2023 (actual)
Nov 16, 2026
Study completion
Dec 31, 2024→Dec 22, 2023 (actual)
Nov 16, 2026
Publications
1 publication citing this study linked from PubMed, e.g. PubMed 37848690 ↗
Nov 16, 2026
Show all 1 update
  1. Nov 16, 2026
    Active, not recruiting→Completed
    Publications 1 publication citing this study linked from PubMed, e.g. PubMed 37848690 ↗
    Primary completion Dec 31, 2024→Sep 21, 2023 (now actual)
    Study completion Dec 31, 2024→Dec 22, 2023 (now actual)

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT04504266
Responsible party
Cindy Kin (Assistant Professor of Surgery, Stanford University) — Principal investigator
First posted
Aug 7, 2020
Start date
Aug 14, 2020
Primary completion
Sep 21, 2023
Completion
Dec 22, 2023
Last update
Nov 16, 2026

Study contacts

Cindy Kin, MD
principal investigator · Stanford University
Brendan Visser, MD
principal investigator · Stanford University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion